Patients with pulmonary arterial hypertension (PAH) can develop several complications with the progression of the disease or as a result of hemodynamic imbalance. Some of these complications include ...

Kate Stringaris, a researcher with the National Heart, Lung, and Blood Institute—a division of the National Institutes of Health in Bethesda, Maryland—separates lymphocytes from a blood sample as part ...

(Getty Images) Dietitians and nutrition played a key role in managing IgAN, participants in a virtual focus group reported. BOSTON—A focus group of patients with immunoglobulin A nephropathy (IgAN) ...

Fire ants are the leading cause of anaphylaxis triggered by Hymenoptera insect stings in the United States. Fire ant (FA) venom-associated anaphylaxis is a significant and growing healthcare burden in ...

The primary drivers of biologic switching in GPP include lack of efficacy, loss of response over time, adverse effects, and safety concerns. Switching biologic therapies for generalized pustular ...

Although there are no current treatment guidelines for GPP in pregnancy, the goal of therapy is to improve prognosis and enhance quality of life, while ensuring the health of both patient and fetus.

Corsair Pharma’s TRX-248 transdermal system demonstrated steady and therapeutically relevant blood levels of treprostinil in preclinical minipig studies. Corsair Pharma successfully completed ...

During the trial, participants will receive RVU120 either on its own or together with ruxolitinib at a dose of 250 mg. A new phase 2 clinical trial testing the efficacy, safety, pharmacodynamics, and ...

(Getty Images) The patient, who had rapid progressive glomerulonephritis and ANCA-positive IgAN, responded well to immunosuppressants. The case study highlights the potential role of IgA in the ...

Over half of the flares led to hospitalization, with 61 out of 97 patients hospitalized for 1 to less than 5 weeks for their most severe flare. Patients with generalized pustular psoriasis (GPP) ...

Consecutive patients ages 18 or above who received a confirmed diagnosis of MF between January 1, 2018, and December 12, 2027, will be enrolled in the study at each site. ERNEST-3, a multicenter ...

Because mast cell disorders comprise a range of clonal and nonclonal mast cell conditions and might share some similar clinical symptoms, a comprehensive diagnostic approach is needed to establish an ...